Can gene therapy done in humans be passed on to future generations?
Updated: Oct 5
Most current gene therapies are designed to target somatic cells, which means they only affect the individual receiving treatment and are not passed down to future generations. These therapies focus on treating specific tissues or organs and do not alter germline cells (sperm or eggs), which are responsible for passing genetic information to offspring.
However, germline gene therapy—which has the potential to alter the genetic makeup of future generations—is a controversial and highly regulated area of research. Ethical and safety concerns currently prevent its use in humans. This distinction is crucial, as the implications of germline modifications could significantly impact not just individual patients but entire families and future generations.
Got more to add on this topic? Share your thoughts in the comments below!
Keep exploring with Gene Tech Times
Free guide: subscribe to the Gene Tech Times Briefing on our homepage and get Every FDA-Approved Gene Therapy at a Glance in your inbox.
Watch: 30-second gene therapy Shorts on Gene Tech Times Academy.
Read: The Cheat Codes of Our Genes, real stories of mutations that make some people immune to disease.
New to gene therapy? Start with The Life-Changing Power of Gene Therapy.
As an Amazon Associate, Gene Tech Times earns from qualifying purchases.
Comments